HLB Life Science R&D has been selected as a demand company in a government-supported project for artificial intelligence (AI) drug development, aiming to enhance its capabilities in this field. The project focuses on establishing a practical research system that connects AI-derived candidate substances with actual efficacy verification.
On June 23, HLB Life Science R&D announced that it has been chosen as a demand company in the 'Link-up - Four Domain AX Program' under the 'Super Gap Startup Project' promoted by the Ministry of SMEs and Startups.
This initiative combines the drug development expertise of pharmaceutical and biotech companies with the AI technology of startups to collaboratively discover and optimize new drug candidates.
As a demand company, HLB Life Science R&D will provide information on target proteins and analyze the efficacy and effectiveness of the discovered active substances. Startups will be responsible for establishing drug discovery strategies based on target protein structure analysis, deriving effective substances, and optimizing structures.
The company plans to build a practical research system that leads AI-suggested candidate substances to actual efficacy verification, aiming to secure lead compounds that can enter non-clinical trials.
AI-based drug development is gaining attention as a next-generation technology that can reduce development time and costs, but connecting the derivation of effective substances with experimental validation remains a key challenge. HLB Life Science R&D intends to explore opportunities for expanded joint development, technology utilization contracts, and new pipeline collaborations based on the substances and data secured through this project.
An HLB Life Science R&D official stated, "For AI drug development to lead to actual candidate substance discovery, experimental validation capabilities are crucial. We will leverage our own research and development (R&D) center's capabilities to enhance discovery efficiency and continue to pursue pipeline expansion."
The company has recently demonstrated its R&D competitiveness by being selected for several major national research and development projects. Last month, it participated as a collaborative research institution in a project led by the Ministry of Agriculture, Food and Rural Affairs focused on developing a platform for cannabidiol raw materials and cultivation technology.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.